Erratum: Antibodies to S. aureus LukS-PV attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs (PLoS ONE 10:9 (e0137874) (DOI:10.1371/journal.pone.0137874));Antibodies to S. aureus LukS-PV attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Adhikari, Rajan P ^a   Kort, Thomas ^a   Shulenin, Sergey ^a   Kanipakala, Tulasikumari ^a   Ganjbaksh, Nader ^a   Roghmann, Mary Claire ^b,c   Holtsberg, Frederick W ^a   Aman, M Javad ^a  

^a Integrated BioTherapeutics Inc   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; ALPHA TOXIN; HLGA TOXIN; HLGB TOXIN; HLGC TOXIN; IMMUNOGLOBULIN G ANTIBODY; LEUKOTOXIN; LUKA TOXIN; LUKB TOXIN; LUKD TOXIN; LUKE TOXIN; LUKF PV TOXIN; LUKS PV TOXIN; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; STAPHYLOCOCCUS VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; ANTIBODY; BACTERIAL PROTEIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; LEUKOCIDIN AB, STAPHYLOCOCCUS AUREUS; LEUKOCIDIN S-COMPONENT PROTEIN, STAPHYLOCOCCUS; LIVE VACCINE; LUKD PROTEIN, STAPHYLOCOCCUS AUREUS; PANTON-VALENTINE LEUKOCIDIN;

ADULT; ALPHA TOXIN HEMOLYTIC AND NEUTRALIZATION ASSAY; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; INFECTION RISK; LETHALITY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; STAPHYLOCOCCAL BACTEREMIA; TOXICITY AND INTOXICATION; TOXIN NEUTRALIZATION; TOXIN SYNTHESIS; ANIMAL; BAGG ALBINO MOUSE; CROSS REACTION; CYTOTOXICITY TEST; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MICROBIOLOGY; PATHOGENICITY; RABBIT; SERODIAGNOSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CROSS REACTIONS; CYTOTOXICITY TESTS, IMMUNOLOGIC; EXOTOXINS; FEMALE; HUMANS; LEUKOCIDINS; MICE, INBRED BALB C; MICE, INBRED ICR; NEUTRALIZATION TESTS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINES, ATTENUATED;

EID: 84947718172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143493     Document Type: Erratum

References (50)

1. Tristan A, Ferry T, Durand G, Dauwalder O, Bes M, Lina G, et al. Virulence determinants in community and hospital meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2007; 65 Suppl 2:105-9. Epub 2007/08/19. doi: S0195-6701(07)60025-5 [pii] doi: 10.1016/S0195-6701(07)60025-5 PMID: 17540252.
2. Nizet V. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol. 2007; 120(1):13-22. Epub 2007/07/04. doi: S0091-6749(07) 01048-2 [pii] doi: 10.1016/j.jaci.2007.06.005 PMID: 17606031.
3. Skurnik D, Kropec A, Roux D, Theilacker C, Huebner J, Pier GB. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy. Clin Infect Dis. 2012; 55(9):1188-97. Epub 2012/07/19. doi: 10.1093/cid/cis624 cis624 [pii]. PMID: 22806596; Pub Med Central PMCID: PMC3529611.
4. Pozzi C, Wilk K, Lee JC, Gening M, Nifantiev N, Pier GB. Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. PLoS One. 2012; 7 (10):e46648. Epub 2012/10/19. doi: 10.1371/journal.pone.0046648 PONE-D-12-16741 [pii]. PMID: 23077517; Pub Med Central PMCID: PMC3471903.
5. Lattar SM, Noto Llana M, Denoel P, Germain S, Buzzola FR, Lee JC, et al. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis. Infect Immun. 2014; 82(1):83-91. Epub 2013/10/16. doi: 10.1128/IAI.01050-13 IAI.01050-13 [pii]. PMID: 24126523; Pub Med Central PMCID: PMC3911846.
6. Salgado-Pabon W, Schlievert PM. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol. 2014; 12(8):585-91. Epub 2014/07/08. doi: 10.1038/nrmicro3308 nrmicro3308 [pii]. PMID: 24998740.
7. Merck. Efficacy, Immunogenicity, and safety of a single dose of V710 in adult patients scheduled for cardiothoracic surgery (V710-003 AM2). 2012.
8. Alonzo F 3rd, Kozhaya L, Rawlings SA, Reyes-Robles T, Du Mont AL, Myszka DG, et al. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature. 2013; 493(7430):51-5. Epub 2012/12/14. doi: 10.1038/nature11724 nature11724 [pii]. PMID: 23235831; Pub Med Central PMCID: PMC3536884.
9. Gauduchon V, Werner S, Prevost G, Monteil H, Colin DA. Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun. 2001; 69(4):2390-5. Epub 2001/03/20. doi: 10.1128/IAI.69.4.2390-2395.2001 PMID: 11254598; Pub Med Central PMCID: PMC98170.
10. Ozawa T, Kaneko J, Kamio Y. Essential binding of LukF of staphylococcal gamma-hemolysin followed by the binding of H gamma II for the hemolysis of human erythrocytes. Biosci Biotechnol Biochem. 1995; 59(6):1181-3. Epub 1995/06/01. PMID: 7613012.
11. Sugawara N, Tomita T, Sato T, Kamio Y. Assembly of Staphylococcus aureus leukocidin into a poreforming ring-shaped oligomer on human polymorphonuclear leukocytes and rabbit erythrocytes. Biosci Biotechnol Biochem. 1999; 63(5):884-91. Epub 1999/06/25. PMID: 10380630.
12. Diep BA, Otto M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 2008; 16(8):361-9. Epub 2008/07/01. doi: 10.1016/j.tim.2008.05.002 S0966-842X (08)00131-5 [pii]. PMID: 18585915; Pub Med Central PMCID: PMC2778837.
13. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006; 367(9512):731-9. Epub 2006/03/07. doi: S0140-6736(06)68231-7 [pii] doi: 10.1016/S0140-6736 (06)68231-7 PMID: 16517273.
14. Kaneko J, Kimura T, Narita S, Tomita T, Kamio Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes. Gene. 1998; 215(1):57-67. Epub 1998/07/17. doi: S0378111998002789 [pii]. PMID: 9666077.
15. Narita S, Kaneko J, Chiba J, Piemont Y, Jarraud S, Etienne J, et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene. 2001; 268(1-2):195-206. Epub 2001/05/23. doi: S0378111901003900 [pii]. PMID: 11368915.
16. Kaneko J, Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004; 68(5):981-1003. Epub 2004/06/01. PMID: 15170101.
17. Joubert O, Viero G, Keller D, Martinez E, Colin DA, Monteil H, et al. Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions. Biochem J. 2006; 396(2):381-9. Epub 2006/02/24. doi: BJ20051878 [pii] doi: 10.1042/BJ20051878 PMID: 16494579.
18. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS One. 2011; 6(4):e18617. Epub 2011/04/29. doi: 10.1371/journal.pone.0018617 PMID: 21525981.
19. Alonzo F 3rd, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol. 2012; 83(2):423-35. Epub 2011/12/07. doi: 10.1111/j.1365-2958.2011.07942.x PMID: 22142035.
20. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, Kreiswirth BN, et al. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol. 2011; 79 (3):814-25. Epub 2011/01/25. doi: 10.1111/j.1365-2958.2010.07490.x PMID: 21255120.
21. Loffler B, Hussain M, Grundmeier M, Bruck M, Holzinger D, Varga G, et al. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 2010; 6 (1):e1000715. Epub 2010/01/15. doi: 10.1371/journal.ppat.1000715 PMID: 20072612; Pub Med Central PMCID: PMC2798753.
22. Karauzum H, Adhikari RP, Sarwar J, Devi VS, Abaandou L, Haudenschild C, et al. Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model. PLoS One. 2013; 8(6):e65384. Epub 2013/06/14. doi: 10.1371/journal. pone.0065384 PONE-D-13-10133 [pii]. PMID: 23762356.
23. Aman MJ, Adhikari RP. Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy. Toxins (Basel). 2014; 6(3):950-72. Epub 2014/03/07. doi: 10.3390/toxins6030950 toxins6030950 [pii]. PMID: 24599233; Pub Med Central PMCID: PMC3968370.
24. Ferreras M, Hoper F, Dalla Serra M, Colin DA, Prevost G, Menestrina G. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Biochim Biophys Acta. 1998; 1414(1-2):108-26. Epub 1998/11/07. PMID: 9804914.
25. Adhikari RP, Karauzum H, Sarwar J, Abaandou L, Mahmoudieh M, Boroun AR, et al. Novel structurally designed vaccine for S. aureus alpha-hemolysin: protection against bacteremia and pneumonia. PLoS One. 2012; 7(6):e38567. Epub 2012/06/16. doi: 10.1371/journal.pone.0038567 PONE-D-12-06043 [pii]. PMID: 22701668; Pub Med Central PMCID: PMC3368876.
26. Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis. 2012; 206(6):915-23. Epub 2012/07/19. doi: 10.1093/infdis/jis462 jis462 [pii]. PMID: 22807524.
27. Wergeland HI, Haaheim LR, Natas OB, Wesenberg F, Oeding P. Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol. 1989; 27(6):1286-91. Epub 1989/06/01. PMID: 2473994; Pub Med Central PMCID: PMC267543.
28. Du Mont AL, Yoong P, Liu X, Day CJ, Chumbler NM, James DB, et al. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect Immun. 2014; 82(3):1268-76. Epub 2014/01/01. doi: 10.1128/IAI.01444-13 IAI.01444-13 [pii]. PMID: 24379286; Pub Med Central PMCID: PMC3958006.
29. Gravet A, Colin DA, Keller D, Girardot R, Monteil H, Prevost G. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 1998; 436 (2):202-8. Epub 1998/10/22. doi: S0014579398011302 [pii]. PMID: 9781679.
30. Malachowa N, Kobayashi SD, Braughton KR, Whitney AR, Parnell MJ, Gardner DJ, et al. Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis. 2012; 206(8):1185-93. Epub 2012/08/09. doi: jis495 [pii] doi: 10.1093/infdis/jis495 PMID: 22872735; Pub Med Central PMCID: PMC3448972.
31. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, Aerts PC, et al. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe. 2013; 13(5):584-94. Epub 2013/05/21. doi: 10.1016/j.chom.2013.04.006 S1931-3128(13)00148-0 [pii]. PMID: 23684309.
32. Finck-Barbancon V, Duportail G, Meunier O, Colin DA. Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta. 1993; 1182(3):275-82. Epub 1993/10/20. PMID: 8399361.
33. Holzinger D, Gieldon L, Mysore V, Nippe N, Taxman DJ, Duncan JA, et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J Leukoc Biol. 2012; 92(5):1069-81. Epub 2012/08/16. doi: 10.1189/jlb.0112014 jlb.0112014 [pii]. PMID: 22892107; Pub Med Central PMCID: PMC3476237.
34. Miles G, Movileanu L, Bayley H. Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci. 2002; 11(4):894-902. Epub 2002/03/23. doi: 10.1110/ps.4360102 PMID: 11910032; Pub Med Central PMCID: PMC2373538.
35. Villaruz AE, Bubeck Wardenburg J, Khan BA, Whitney AR, Sturdevant DE, Gardner DJ, et al. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis. 2009; 200(5):724-34. Epub 2009/07/17. doi: 10.1086/604728 PMID: 19604047; Pub Med Central PMCID: PMC2777534.
36. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, De Leo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis. 2008; 198(8):1166-70. Epub 2008/08/30. doi: 10.1086/592053 PMID: 18729780; Pub Med Central PMCID: PMC2574921.
37. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006; 194(12):1761-70. Epub 2006/11/17. doi: JID36574 [pii] doi: 10.1086/509506 PMID: 17109350.
38. Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect. 2009; 15(2):156-64. Epub 2009/01/22. doi: 10.1111/j.1469-0691.2008. 02648.x CLM2648 [pii]. PMID: 19154186; Pub Med Central PMCID: PMC2657196.
39. Cremieux AC, Dumitrescu O, Lina G, Vallee C, Cote JF, Muffat-Joly M, et al. Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009; 4(9):e7204. Epub 2009/09/26. doi: 10.1371/journal.pone.0007204 PMID: 19779608.
40. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A. 2010; 107(12):5587-92. Epub 2010/03/17. doi: 0912403107 [pii] doi: 10.1073/pnas.0912403107 PMID: 20231457.
41. Varshney AK, Martinez LR, Hamilton SM, Bryant AE, Levi MH, Gialanella P, et al. Augmented Production of Panton-Valentine Leukocidin Toxin in Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Is Associated with Worse Outcome in a Murine Skin Infection Model. J Infect Dis. 2009. Epub 2009/11/26. doi: 10.1086/648613 PMID: 19929693.
42. Spaan AN, Vrieling M, Wallet P, Badiou C, Reyes-Robles T, Ohneck EA, et al. The staphylococcal toxins gamma-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat Commun. 2014; 5:5438. Epub 2014/11/12. doi: 10.1038/ncomms6438 ncomms6438 [pii]. PMID: 25384670; Pub Med Central PMCID: PMC4228697.
43. Arciola CR, Baldassarri L, Von Eiff C, Campoccia D, Ravaioli S, Pirini V, et al. Prevalence of genes encoding for staphylococcal leukocidal toxins among clinical isolates of Staphylococcus aureus from implant orthopedic infections. Int J Artif Organs. 2007; 30(9):792-7. Epub 2007/10/06. PMID: 17918124.
44. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol. 1995; 42(4):237-45. Epub 1995/04/01. PMID: 7707330.
45. Malachowa N, De Leo FR. Staphylococcus aureus survival in human blood. Virulence. 2011; 2(6):567-9. Epub 2011/10/06. doi: 10.4161/viru.2.6.17732 17732 [pii]. PMID: 21971187; Pub Med Central PMCID: PMC3260549.
46. Nilsson IM, Hartford O, Foster T, Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun. 1999; 67(3):1045-9. Epub 1999/02/20. PMID: 10024541; Pub Med Central PMCID: PMC96427.
47. Du Mont AL, Yoong P, Day CJ, Alonzo F 3rd, McDonald WH, Jennings MP, et al. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A. 2013; 110(26):10794-9. Epub 2013/06/12. doi: 10.1073/pnas.1305121110 1305121110 [pii]. PMID: 23754403; Pub Med Central PMCID: PMC3696772.
48. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007; 315(5815):1130-3. Epub 2007/01/20. doi: 1137165 [pii] doi: 10.1126/science.1137165 PMID: 17234914.
49. Siqueira JA, Speeg-Schatz C, Freitas FI, Sahel J, Monteil H, Prevost G. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. J Med Microbiol. 1997; 46(6):486-94. Epub 1997/06/01. PMID: 9350201.
50. Prevost G, Cribier B, Couppie P, Petiau P, Supersac G, Finck-Barbancon V, et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun. 1995; 63(10):4121-9. Epub 1995/10/01. PMID: 7558328.